About
Revel Pharmaceuticals develops engineered enzymes as therapeutics to recognize and reverse age-related molecular damage—including collagen crosslinks, glycation, and crystal or crystal-like accumulations—to address conditions such as neurodegeneration, heart disease, arthritis, skin aging, and gout.
Explore Revel Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.